Entegrion Receives $1.9 Million from Navy for Blood Product and…

Funding applied to Phase 1 studies for ResusixTM, a spray-dried, solvent detergent-treated human plasma, and for further development of a Multi-functional Resuscitation Fluid (MRF) that provides a...

(PRWeb July 31, 2012)

Read the full story at http://www.prweb.com/releases/20120731EntegrionWinsNavy/ContractForAlmost2M/prweb9754941.htm

Comments are closed.